Gum-Sized AI device could prevent deadly potassium spikes in kidney patients
NCT ID NCT06901960
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a small, AI-powered ECG device that looks like a stick of gum to help people with moderate-to-advanced chronic kidney disease monitor their potassium levels at home. Participants will use the device at least twice a week and receive alerts if levels are abnormal. The goal is to see if frequent monitoring reduces dangerous high potassium episodes over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AI-enhanced electrocardiogram device
What this could lead to
If successful, this device could help people with chronic kidney disease avoid dangerous high potassium levels by catching them early and prompting action.
What could go wrong
This is a relatively early-stage trial with 1066 participants, and the device's accuracy may vary in real-world use. It is not a treatment for kidney disease itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE (STAGES 3B-5) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hubei Provincial Hospital of TCM
NOT_YET_RECRUITINGWuhan, Hubei, 430063, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, 100034, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Guangxi Medical University
NOT_YET_RECRUITINGNanning, Guangxi, 530021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••